Your browser doesn't support javascript.
loading
Inotuzumab ozogamicin versus FLAG-Ida in the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia - real-world resource use data.
Lecat, Catherine S Y; Besley, Caroline; Hough, Rachael E; Khwaja, Asim; Furness, Caroline; Marks, David I; Fielding, Adele K.
Affiliation
  • Lecat CSY; Department of Haematology, University College London Hospitals, London, UK.
  • Besley C; Bristol Haematology & Oncology Centre, University Hospitals Bristol, Bristol, UK.
  • Hough RE; Department of Haematology, University College London Hospitals, London, UK.
  • Khwaja A; UCL Cancer Institute, London, UK.
  • Furness C; Bristol Haematology & Oncology Centre, University Hospitals Bristol, Bristol, UK.
  • Marks DI; Bristol Haematology & Oncology Centre, University Hospitals Bristol, Bristol, UK.
  • Fielding AK; UCL Cancer Institute, London, UK.
Leuk Lymphoma ; 61(2): 491-493, 2020 02.
Article in En | MEDLINE | ID: mdl-31580171
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Precursor Cell Lymphoblastic Leukemia-Lymphoma Limits: Humans Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2020 Document type: Article Affiliation country: Reino Unido Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Precursor Cell Lymphoblastic Leukemia-Lymphoma Limits: Humans Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2020 Document type: Article Affiliation country: Reino Unido Country of publication: Estados Unidos